Viatris (VTRS) announced that Matthew Maletta has been appointed Chief Legal Officer effective February 9. The appointment follows the transition of the company’s current CLO, Brian Roman, after more than 20 years of service to Viatris and its predecessor company, Mylan. Roman will stay on through April 1 to ensure a smooth transition. From 2015 to 2025, Maletta served as EVP, CLO and Corporate Secretary at Endo, where he oversaw Endo’s merger with Mallinckrodt and the subsequent spin-off of Par Health. Prior to that, he served for over a decade in the legal department at Allergan, rising to Vice President, Associate General Counsel and Corporate Secretary. During his early career, Maletta was an Associate Attorney at Skadden, Arps, Slate, Meagher and Flom.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTRS:
- Viatris price target raised to $12 from $9 at Piper Sandler
- Viatris announces Inpefa launch in the United Arab Emirates
- Argus upgrades Viatris to Buy on expected buybacks, debt reduction
- Viatris upgraded to Buy from Hold at Argus
- Viatris says no longer going through period of revenue, EBITDA decline
